What to do when CAR Ts are not the most appropriate option in 2L DLBCL: Current treatment options for transplant-ineligible patients - European Medical Journal

Continue

What to do when CAR Ts are not the most appropriate option in 2L DLBCL: Current treatment options for transplant-ineligible patients

Hematology
An innovative session highlighting patient-focused decision-making and a dynamic debate on current 2L DLBCL treatment options.

 

This content was funded by Incyte

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given